すべての画像(1)
About This Item
化学式:
MgSO4 · 7H2O
CAS番号:
分子量:
246.47
EC Number:
MDL番号:
UNSPSCコード:
12352302
PubChem Substance ID:
アッセイ:
≥99.0%
グレード:
SAJ first grade
フォーム:
fine crystals
おすすめの製品
グレード
SAJ first grade
蒸気密度
<0.01 (vs air)
蒸気圧
<0.1 mmHg ( 20 °C)
アッセイ
≥99.0%
フォーム
fine crystals
利用可能性
available only in Japan
pH
5.0-8.0 (50 g/L)
SMILES記法
O.O.O.O.O.O.O.[Mg++].[O-]S([O-])(=O)=O
InChI
1S/Mg.H2O4S.7H2O/c;1-5(2,3)4;;;;;;;/h;(H2,1,2,3,4);7*1H2/q+2;;;;;;;;/p-2
InChI Key
WRUGWIBCXHJTDG-UHFFFAOYSA-L
類似した製品をお探しですか？ 訪問 製品比較ガイド
保管分類コード
13 - Non Combustible Solids
WGK
WGK 1
引火点(°F)
Not applicable
引火点(℃)
Not applicable
個人用保護具 (PPE)
Eyeshields, Gloves, type N95 (US)
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
Jan Code
19-0490-8-25KG-J:
19-0490-5-500G-J:
Ran D Goldman et al.
Pediatrics, 132(6), e1634-e1641 (2013-11-28)
Vaso-occlusive episodes (VOEs) are the most common complication of sickle cell disease in children. Treatment with magnesium seems to improve cellular hydration and may result in reduced vaso-occlusion. This study aimed to determine if intravenous (IV) magnesium sulfate (MgSO4) reduces
Oluwakemi Badaki-Makun et al.
Pediatric blood & cancer, 61(6), 1049-1054 (2014-01-21)
Multiple recent Sickle Cell Disease studies have been terminated due to poor enrollment. We developed methods to overcome past barriers and utilized these to study the efficacy and safety of intravenous magnesium for vaso-occlusive crisis (VOC). We describe the methods
E S Bain et al.
BJOG : an international journal of obstetrics and gynaecology, 121(5), 595-603 (2014-01-07)
To evaluate a slower (compared with a standard) infusion rate of the loading dose of magnesium sulphate for preterm fetal neuroprotection as a strategy to reduce maternal adverse effects. Randomised controlled trial. South Australian maternity hospital. Fifty-one women at <30
N Arulkumaran et al.
Best practice & research. Clinical obstetrics & gynaecology, 27(6), 877-884 (2013-08-22)
Hypertensive disorders of pregnancy are one of the leading causes of peripartum morbidity and mortality globally. Hypertensive disease in pregnancy is associated with a spectrum of severity, ranging from mild pregnancy-induced hypertension to eclampsia. Although most cases of pre-eclampsia may
Chris Chin
Artificial organs, 37(1), 100-102 (2013-01-12)
Congenital heart disease (CHD) is relatively common and there are treatment options for virtually every form of CHD. With good care, the majority of babies can survive to adulthood; however, CHD remains a significant cause of death in infancy and
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）